Biogened S.A. (WSE:BGD)

Biogened Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.13	6.32	6.07	7.51	3.46	4.97
Cash & Short-Term Investments	7.13	6.32	6.07	7.51	3.46	4.97
Cash Growth	47.19%	4.18%	-19.22%	117.37%	-30.41%	82.21%
Accounts Receivable	20.73	14.76	11.38	10.34	10.46	15.33
Other Receivables	5.98	4.65	8.09	7.52	8.85	7.74
Receivables	26.71	19.4	19.47	17.86	19.31	23.07
Inventory	22.31	19.23	25.48	18.46	19.61	11.47
Other Current Assets	-	3.56	-	-	-	-
Total Current Assets	56.15	48.51	51.02	43.84	42.38	39.5
Property, Plant & Equipment	27.22	27.89	26.47	26.33	21.94	15.94
Other Intangible Assets	1.9	2.03	0.48	0.45	0.56	0.79
Long-Term Deferred Tax Assets	0.94	0.9	0.94	-	-	-
Long-Term Deferred Charges	-	6.4	4.01	-	-	0.03
Other Long-Term Assets	9.48	1.49	3.49	7.89	6.4	4.75
Total Assets	95.69	87.23	86.4	78.51	71.28	61.02

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	15.04	13.54	14.71	15.17	10.17	6.89
Accrued Expenses	2.31	1.98	2.16	1.84	1.5	1.27
Current Portion of Long-Term Debt	9.38	6.68	2.22	11.3	2.53	10.59
Current Portion of Leases	1.32	1.21	1.49	1.62	1.26	0.87
Current Income Taxes Payable	0.91	1.33	1.42	1.52	3.13	3.05
Current Unearned Revenue	-	0.44	0.15	0.15	0.23	0.26
Other Current Liabilities	0.07	0.08	0.07	0.1	0.06	0.05
Total Current Liabilities	29.04	25.27	22.23	31.7	18.88	22.97
Long-Term Debt	16.56	14.29	20.06	6.47	16.76	6.73
Long-Term Leases	1.92	2.06	2.34	3.07	2.43	0.51
Long-Term Unearned Revenue	-	0.34	0.2	0.35	0.46	0.69
Pension & Post-Retirement Benefits	0.2	0.13	0.2	0.22	0.16	0.17
Long-Term Deferred Tax Liabilities	0.09	0.13	0.09	-	-	-
Total Liabilities	48.44	42.22	45.1	41.8	38.69	31.07

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	24.56	24.56	24.56	24.56	24.56	24.56
Additional Paid-In Capital	15.51	15.51	10.92	7.05	4.65	29.68
Retained Earnings	7.18	4.94	5.82	5.1	3.38	-24.29
Shareholders' Equity	47.25	45.02	41.3	36.71	32.59	29.95
Total Liabilities & Equity	95.69	87.23	86.4	78.51	71.28	61.02

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	29.18	24.25	26.1	22.46	22.98	18.7
Net Cash (Debt)	-22.04	-17.92	-20.03	-14.94	-19.52	-13.74
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.97	-7.30	-8.16	-6.08	-7.95	-5.59
Filing Date Shares Outstanding	2.46	2.46	2.46	2.46	2.46	2.46
Total Common Shares Outstanding	2.46	2.46	2.46	2.46	2.46	2.46
Working Capital	27.11	23.25	28.79	12.14	23.51	16.53
Book Value Per Share	19.24	18.33	16.81	14.94	13.27	12.19
Tangible Book Value	45.35	42.98	40.82	36.26	32.03	29.16
Tangible Book Value Per Share	18.46	17.50	16.62	14.76	13.04	11.87
Land	-	0.92	0.92	0.92	0.92	0.92
Buildings	-	21.2	21.11	11.96	11.81	11.63
Machinery	-	29.93	26.1	24.14	19.35	17.24
Construction In Progress	-	0.63	0.29	8.35	7.43	1.53

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error